Catalyst Wire Dossier Catalyst Wire Dossier

INV-101

INV-101 · Inversago Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INV-101, covering 2025-03-30 to 2025-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects [Phase 1]

See pricing